In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

Uterine cancer is one of the few cancers with increasing mortality; since the mid-2000s the death rate has risen by 1.7% per year. Black women are more likely to die from it. There are more than ...

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II drugs for Uterine Cancer have a 30% phase transition success rate ...

Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...

Endometrial cancer originates in the endometrium ... assessed progression-free survival based on the Response Evaluation Criteria in Solid Tumours v1.1 and OS. At the two-and-a-half-year mark, the ...

Major question we raise here – which group of patients is the most favorable to achieve durable immunotherapy response in endometrial cancer? Table 1. Efficacy of immune checkpoint therapy in ...

While a persistent, low-grade fever can occur with many different types of cancer, it is not diagnostic of cancer on its own. A fever can accompany a great many illnesses, the vast majority of which ...